Literature DB >> 8991512

Human melanoma and Chinese hamster ovary cells galactosylate n-alkyl-beta-glucosides using UDP gal:GlcNAc beta 1,4 galactosyltransferase.

A Pörtner1, J R Etchison, D Sampath, H H Freeze.   

Abstract

We previously showed that human melanoma, CHO and other cells can convert beta-xylosides into structural analogs of ganglioside GM3. We have investigated several potential acceptors including a series of n-alkyl-beta-D-glucosides (n = 6-9). All were labeled with 3H-galactose when incubated with human melanoma cells. Octyl-beta-D-glucoside (Glc beta Octyl) was the best acceptor, whereas neither octyl-alpha-D-glucoside nor N-octanoyl-methylglucamine (MEGA 8) were labeled. Analysis of the products by a combination of chromatographic methods and specific enzyme digestions showed that the acceptors first received a single Gal beta 1,4 residue followed by an alpha 2,3 linked sialic acid. Synthesis of these products did not affect cell viability, adherence, protein biosynthesis, or incorporation of radiolabeled precursors into glycoprotein, glycolipid or proteoglycans. To determine which beta 1,4 galactosyl transferase synthesized Gal beta 1,4Glc beta Octyl, we analyzed similar incubations using CHO cells and a mutant CHO line (CHO 761) which lacks GAG-core specific beta 1,4 galactosyltransferase. The mutant cells showed the same level of incorporation as the control, eliminating this enzyme as a candidate. Thermal inactivation kinetics using melanoma cell microsomes and rat liver Golgi to galactosylate Glc beta Octyl showed the same half-life as UDP-Gal:GlcNAc beta 1,4 galactosyltransferase, whereas LacCer synthase was inactivated at a much faster rate. We show that Glc beta Octyl is a substrate for purified bovine milk UDP-Gal:GlcNAc beta 1,4 galactosyltransferase. Furthermore, the galactosylation of Glc beta Octyl by CHO cell microsomes can be competitively inhibited by GlcNAc or GlcNAc beta MU. These results indicate that UDP-Gal:GlcNAc beta 1,4 galactosyltransferase is the enzyme used for the synthesis of the alkyl lactosides when cells or rat liver Golgi are incubated with alkyl beta glucosides.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8991512     DOI: 10.1093/glycob/6.1.7

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  1 in total

1.  SLC35A2-CDG: Functional characterization, expanded molecular, clinical, and biochemical phenotypes of 30 unreported Individuals.

Authors:  Bobby G Ng; Paulina Sosicka; Satish Agadi; Mohammed Almannai; Carlos A Bacino; Rita Barone; Lorenzo D Botto; Jennifer E Burton; Colleen Carlston; Brian Hon-Yin Chung; Julie S Cohen; David Coman; Katrina M Dipple; Naghmeh Dorrani; William B Dobyns; Abdallah F Elias; Leon Epstein; William A Gahl; Domenico Garozzo; Trine Bjørg Hammer; Jaclyn Haven; Delphine Héron; Matthew Herzog; George E Hoganson; Jesse M Hunter; Mahim Jain; Jane Juusola; Shenela Lakhani; Hane Lee; Joy Lee; Katherine Lewis; Nicola Longo; Charles Marques Lourenço; Christopher C Y Mak; Dianalee McKnight; Bryce A Mendelsohn; Cyril Mignot; Ghayda Mirzaa; Wendy Mitchell; Hiltrud Muhle; Stanley F Nelson; Mariusz Olczak; Christina G S Palmer; Arthur Partikian; Marc C Patterson; Tyler M Pierson; Shane C Quinonez; Brigid M Regan; M Elizabeth Ross; Maria J Guillen Sacoto; Fernando Scaglia; Ingrid E Scheffer; Devorah Segal; Nilika Shah Singhal; Pasquale Striano; Luisa Sturiale; Joseph D Symonds; Sha Tang; Eric Vilain; Mary Willis; Lynne A Wolfe; Hui Yang; Shoji Yano; Zöe Powis; Sharon F Suchy; Jill A Rosenfeld; Andrew C Edmondson; Stephanie Grunewald; Hudson H Freeze
Journal:  Hum Mutat       Date:  2019-04-24       Impact factor: 4.878

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.